BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 11828267)

  • 1. Insulin-Like Growth Factors and Their Binding Proteins in Tumors and Ascites of Ovarian Cancer Patients: Association With Response To Neoadjuvant Chemotherapy.
    Yunusova NV; Villert AB; Spirina LV; Frolova AE; Kolomiets LA; Kondakova IV
    Asian Pac J Cancer Prev; 2016 Dec; 17(12):5315-5320. PubMed ID: 28125879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
    Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY; Choi BG; Choi JY; Lee SY; Ju SY
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in ovarian cancer.
    de Souza PL; Friedlander ML
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):761-82. PubMed ID: 1500385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.
    Amutha P; Rajkumar T
    Indian J Med Paediatr Oncol; 2017; 38(2):198-206. PubMed ID: 28900330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and prognostic significance in epithelial ovarian cancer].
    Katsaros D; Yu H; Piccinno R; Puopolo M; Rigault De La Longrais IA; Fracchioli S; Massobrio M
    Minerva Ginecol; 2002 Feb; 54(1):15-24. PubMed ID: 11828267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of ovarian cancer of epithelial origin.
    Rabinerson D; Kaplan B; Levavi H; Neri A
    Isr J Med Sci; 1996 Nov; 32(11):1128-33. PubMed ID: 8960089
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.